Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Magerl

Showing results (101-110 of 152) with videos related to

Pageof 16
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 21, 2016
Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema: Findings from an international patient registryMarkus Magerl, Michael Frank, William Lumry, et al.
Frontiers in Allergy|July 25, 2022
Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE)Faidra Parsopoulou, Gedeon Loules, Maria Zamanakou, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 22, 2026
Global Real-World Validation of First-Day Urticaria Activity Score (UAS1)Lanka Huidong Su, Bernardo Sousa Pinto, Aiste Ramanauskaite, et al.
The Journal of Allergy and Clinical Immunology|June 16, 2016
Prophylaxis of hereditary angioedema attacks: A randomized trial of oral plasma kallikrein inhibition with avoralstatEmel Aygören-Pürsün, Markus Magerl, Jochen Graff, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 14, 2017
Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patientsPaula Busse, James Baker, Inmaculada Martinez-Saguer, et al.
Frontiers in Immunology|January 28, 2026
Classification of angioedema types using decision tree modelingFelix Aulenbacher, Annika Gutsche, Henriette Farkas, et al.
Allergy|October 7, 2024
Long-term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open-label extension studyAvner Reshef, Connie Hsu, Constance H Katelaris, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 29, 2023
A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxisJoan Mendivil, Maral DerSarkissian, Aleena Banerji, et al.
Allergy & Rhinology (Providence, R.I.)|April 7, 2017
Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedemaTimothy Craig, Ralph Shapiro, Arthur Vegh, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 15, 2021
The Diagnostic Workup in Chronic Spontaneous Urticaria-What to Test and WhyMartin Metz, Sabine Altrichter, Thomas Buttgereit, et al.
Pageof 16

Showing results (101-110 of 152) with videos related to

Sort By:
Pageof 16
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 21, 2016
Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema: Findings from an international patient registryMarkus Magerl, Michael Frank, William Lumry, et al.
Frontiers in Allergy|July 25, 2022
Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE)Faidra Parsopoulou, Gedeon Loules, Maria Zamanakou, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 22, 2026
Global Real-World Validation of First-Day Urticaria Activity Score (UAS1)Lanka Huidong Su, Bernardo Sousa Pinto, Aiste Ramanauskaite, et al.
The Journal of Allergy and Clinical Immunology|June 16, 2016
Prophylaxis of hereditary angioedema attacks: A randomized trial of oral plasma kallikrein inhibition with avoralstatEmel Aygören-Pürsün, Markus Magerl, Jochen Graff, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 14, 2017
Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patientsPaula Busse, James Baker, Inmaculada Martinez-Saguer, et al.
Frontiers in Immunology|January 28, 2026
Classification of angioedema types using decision tree modelingFelix Aulenbacher, Annika Gutsche, Henriette Farkas, et al.
Allergy|October 7, 2024
Long-term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open-label extension studyAvner Reshef, Connie Hsu, Constance H Katelaris, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 29, 2023
A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxisJoan Mendivil, Maral DerSarkissian, Aleena Banerji, et al.
Allergy & Rhinology (Providence, R.I.)|April 7, 2017
Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedemaTimothy Craig, Ralph Shapiro, Arthur Vegh, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 15, 2021
The Diagnostic Workup in Chronic Spontaneous Urticaria-What to Test and WhyMartin Metz, Sabine Altrichter, Thomas Buttgereit, et al.
Pageof 16